Assuming that information is true which we have not heard officially in a NR that means we are having approximately 5  to 7 MACE events occuring each month instead of the stated  10 to 15 MACE events mentioned from DM at the AGM this September.   Assuming 235 MACE as of now and 3 months to early June to hit 250 MACE events.  Are we having a slowing of the event rate with the placebo group and increased drop out rate or is Apabetalone woking in the test group. That's the $5 to $10 Billion USD question.  With the 8 DSMB positive reports with no stoppage and continuation and the FDA allowing an NDA depending on trial results from last July , Hepa continuing with stopping of adding to their share total  my thinking it just may be the drug working,   I am hoping......